FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064665995> ?p ?o ?g. }

• W2064665995 endingPage "6233" @default.
• W2064665995 startingPage "6221" @default.
• W2064665995 abstract "Among rodent models for brain tumors, the 9L gliosarcoma is one of the most widely used. Our 9L-European Synchrotron Radiation Facility (ESRF) model was developed from cells acquired at the Brookhaven National Laboratory (NY, USA) in 1997 and implanted in the right caudate nucleus of syngeneic Fisher rats. It has been largely used by the user community of the ESRF during the last decade, for imaging, radiotherapy, and chemotherapy, including innovative treatments based on particular irradiation techniques and/or use of new drugs. This work presents a detailed study of its characteristics, assessed by magnetic resonance imaging (MRI), histology, immunohistochemistry, and cytogenetic analysis. The data used for this work were from rats sampled in six experiments carried out over a 3-year period in our lab (total number of rats = 142). The 9L-ESRF tumors were induced by a stereotactic inoculation of 10(4) 9L cells in the right caudate nucleus of the brain. The assessment of vascular parameters was performed by MRI (blood volume fraction and vascular size index) and by immunostaining of vessels (rat endothelial cell antigen-1 and type IV collagen). Immunohistochemistry and regular histology were used to describe features such as tumor cell infiltration, necrosis area, nuclear pleomorphism, cellularity, mitotic characteristics, leukocytic infiltration, proliferation, and inflammation. Moreover, for each of the six experiments, the survival of the animals was assessed and related to the tumor growth observed by MRI or histology. Additionally, the cytogenetic status of the 9L cells used at ESRF lab was investigated by comparative genomics hybridization analysis. Finally, the response of the 9L-ESRF tumor to radiotherapy was estimated by plotting the survival curves after irradiation. The median survival time of 9L-ESRF tumor-bearing rats was highly reproducible (19-20 days). The 9L-ESRF tumors presented a quasi-exponential growth, were highly vascularized with a high cellular density and a high proliferative index, accompanied by signs of inflammatory responses. We also report an infiltrative pattern which is poorly observed on conventional 9 L tumor. The 9L-ESRF cells presented some cytogenetic specificities such as altered regions including CDK4, CDKN2A, CDKN2B, and MDM2 genes. Finally, the lifespan of 9L-ESRF tumor-bearing rats was enhanced up to 28, 35, and 45 days for single doses of 10, 20, and 2 × 20 Gy, respectively. First, this report describes an animal model that is used worldwide. Second, we describe few features typical of our model if compared to other 9L models worldwide. Altogether, the 9L-ESRF tumor model presents characteristics close to the human high-grade gliomas such as high proliferative capability, high vascularization and a high infiltrative pattern. Its response to radiotherapy demonstrates its potential as a tool for innovative radiotherapy protocols." @default.
• W2064665995 created "2016-06-24" @default.
• W2064665995 creator A5001484083 @default.
• W2064665995 creator A5003366087 @default.
• W2064665995 creator A5008751102 @default.
• W2064665995 creator A5012373377 @default.
• W2064665995 creator A5025158118 @default.
• W2064665995 creator A5025716864 @default.
• W2064665995 creator A5042241430 @default.
• W2064665995 creator A5048449652 @default.
• W2064665995 creator A5052444841 @default.
• W2064665995 creator A5060651727 @default.
• W2064665995 creator A5060880357 @default.
• W2064665995 creator A5076803282 @default.
• W2064665995 creator A5086140058 @default.
• W2064665995 date "2014-03-16" @default.
• W2064665995 modified "2023-10-07" @default.
• W2064665995 title "Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor" @default.
• W2064665995 cites W191454705 @default.
• W2064665995 cites W1970064526 @default.
• W2064665995 cites W1972365556 @default.
• W2064665995 cites W1982552890 @default.
• W2064665995 cites W1985156459 @default.
• W2064665995 cites W1988184011 @default.
• W2064665995 cites W2005542290 @default.
• W2064665995 cites W2007196301 @default.
• W2064665995 cites W2020203633 @default.
• W2064665995 cites W2021227540 @default.
• W2064665995 cites W2022912277 @default.
• W2064665995 cites W2038257557 @default.
• W2064665995 cites W2051910121 @default.
• W2064665995 cites W2052835040 @default.
• W2064665995 cites W2065447975 @default.
• W2064665995 cites W2076378464 @default.
• W2064665995 cites W2080423009 @default.
• W2064665995 cites W2084170466 @default.
• W2064665995 cites W2090082231 @default.
• W2064665995 cites W2106580246 @default.
• W2064665995 cites W2108417705 @default.
• W2064665995 cites W2111620238 @default.
• W2064665995 cites W2113942802 @default.
• W2064665995 cites W2119827505 @default.
• W2064665995 cites W2121788419 @default.
• W2064665995 cites W2122610413 @default.
• W2064665995 cites W2125116763 @default.
• W2064665995 cites W2132729928 @default.
• W2064665995 cites W2152211251 @default.
• W2064665995 cites W2157036804 @default.
• W2064665995 cites W2160382843 @default.
• W2064665995 cites W2165778860 @default.
• W2064665995 cites W2322684614 @default.
• W2064665995 cites W2328758956 @default.
• W2064665995 cites W27942811 @default.
• W2064665995 cites W55194647 @default.
• W2064665995 doi "https://doi.org/10.1007/s13277-014-1783-6" @default.
• W2064665995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24633919" @default.
• W2064665995 hasPublicationYear "2014" @default.
• W2064665995 type Work @default.
• W2064665995 sameAs 2064665995 @default.
• W2064665995 citedByCount "34" @default.
• W2064665995 countsByYear W20646659952014 @default.
• W2064665995 countsByYear W20646659952015 @default.
• W2064665995 countsByYear W20646659952016 @default.
• W2064665995 countsByYear W20646659952017 @default.
• W2064665995 countsByYear W20646659952018 @default.
• W2064665995 countsByYear W20646659952019 @default.
• W2064665995 countsByYear W20646659952020 @default.
• W2064665995 countsByYear W20646659952021 @default.
• W2064665995 countsByYear W20646659952022 @default.
• W2064665995 countsByYear W20646659952023 @default.
• W2064665995 crossrefType "journal-article" @default.
• W2064665995 hasAuthorship W2064665995A5001484083 @default.
• W2064665995 hasAuthorship W2064665995A5003366087 @default.
• W2064665995 hasAuthorship W2064665995A5008751102 @default.
• W2064665995 hasAuthorship W2064665995A5012373377 @default.
• W2064665995 hasAuthorship W2064665995A5025158118 @default.
• W2064665995 hasAuthorship W2064665995A5025716864 @default.
• W2064665995 hasAuthorship W2064665995A5042241430 @default.
• W2064665995 hasAuthorship W2064665995A5048449652 @default.
• W2064665995 hasAuthorship W2064665995A5052444841 @default.
• W2064665995 hasAuthorship W2064665995A5060651727 @default.
• W2064665995 hasAuthorship W2064665995A5060880357 @default.
• W2064665995 hasAuthorship W2064665995A5076803282 @default.
• W2064665995 hasAuthorship W2064665995A5086140058 @default.
• W2064665995 hasConcept C126322002 @default.
• W2064665995 hasConcept C142724271 @default.
• W2064665995 hasConcept C204232928 @default.
• W2064665995 hasConcept C2777295375 @default.
• W2064665995 hasConcept C2778227246 @default.
• W2064665995 hasConcept C2779130545 @default.
• W2064665995 hasConcept C2781423529 @default.
• W2064665995 hasConcept C2989005 @default.
• W2064665995 hasConcept C4224716 @default.
• W2064665995 hasConcept C502942594 @default.
• W2064665995 hasConcept C57742111 @default.
• W2064665995 hasConcept C71924100 @default.
• W2064665995 hasConceptScore W2064665995C126322002 @default.
• W2064665995 hasConceptScore W2064665995C142724271 @default.

• next